top of page
Dr. Zach Berman on the BackTable VI Podcast

Dr. Zach Berman

Interventional Radiologist

19 Podcasts • 18 Cases • 4 Courses on BackTable

Dr. Zachary Berman is an interventional radiologist at the University of California San Diego in San Diego, California.

Learn from the experiences and expertise of Dr. Zach Berman and other leading voices in your specialty on the BackTable app.

Principles to Practice: An HCC Tumor Board
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Vascular & Interventional

Episode # 525  •  14 Mar 2025

Principles to Practice: An HCC Tumor Board

Do you ever wish you could be a fly on the wall at a tumor board meeting? In this episode of BackTable, we’re excited to give you an insider’s view of the real case discussions that take place during hepatocellular carcinoma (HCC) tumor boards. Host Dr. Zach Berman sits down with a multidisciplinary team, including Drs. Adam Burgoyne (medical oncologist), Heather Patton (hepatologist), Siddharth Padia (interventional radiologist), and Gabriel Schnickel (transplant and hepatobiliary surgeon).

This podcast is supported by an educational grant from AstraZeneca Pharmaceuticals and Boston Scientific.

More from Dr. Zach Berman

Loading recent podcasts…

HCC: Super Challenging Case with Child-Pugh A Status

VI Case

Jan 24, 2025

HCC: Super Challenging Case with Child-Pugh A Status

HCC: Super Challenging Case with Child-Pugh A Status

HCC: Surgical & Non-Surgical Treatments for a 60-year Old with Solitary LR5

VI Case

Jan 22, 2025

HCC: Surgical & Non-Surgical Treatments for a 60-year Old with Solitary LR5

HCC: Surgical & Non-Surgical Treatments for a 60-year Old with Solitary LR5

HCC: 68-year Old Non-Cirrhotic Patient with an LR5 Lesion

VI Case

Jan 22, 2025

HCC: 68-year Old Non-Cirrhotic Patient with an LR5 Lesion

HCC: 68-year Old Non-Cirrhotic Patient with an LR5 Lesion

HCC: Multifocal Disease in a Non-Cirrhotic Patient

VI Case

Jan 22, 2025

HCC: Multifocal Disease in a Non-Cirrhotic Patient

HCC: Multifocal Disease in a Non-Cirrhotic Patient

HCC: Surgical & Non-Surgical Treatments for a 60-year Old with Solitary LR5

Tumor Board Case

Jan 22, 2025

HCC: Surgical & Non-Surgical Treatments for a 60-year Old with Solitary LR5

HCC: Surgical & Non-Surgical Treatments for a 60-year Old with Solitary LR5

HCC: 68-year Old Non-Cirrhotic Patient with an LR5 Lesion

Tumor Board Case

Jan 22, 2025

HCC: 68-year Old Non-Cirrhotic Patient with an LR5 Lesion

HCC: 68-year Old Non-Cirrhotic Patient with an LR5 Lesion

HCC: Multifocal Disease in a Non-Cirrhotic Patient

Tumor Board Case

Jan 22, 2025

HCC: Multifocal Disease in a Non-Cirrhotic Patient

HCC: Multifocal Disease in a Non-Cirrhotic Patient

HCC: 67-year Old with Cirrhosis, pHTN, 10cm Lesion

VI Case

Jan 22, 2025

HCC: 67-year Old with Cirrhosis, pHTN, 10cm Lesion

HCC: 67-year Old with Cirrhosis, pHTN, 10cm Lesion

Y90 Dosing & Ablation Modalities for HCC

Tumor Board Course

2 hours, 20 lessons

About

Zachary T. Berman, MD is an interventional radiologist who performs minimally invasive image-guided procedures. He specializes in liver-directed therapies for hepatocellular carcinoma and metastatic liver disease such as transarterial radioembolization (TARE/SIRT), transarterial chemoembolization (TACE), and percutaneous ablation (microwave, radiofrequency and cryoablation). He also focuses on the treatment of vascular malformations (arteriovenous malformations and venous malformations) as well as neuroendocrine tumors.
Dr. Berman enjoys using a multidisciplinary approach and works collaboratively with physicians in various specialties to determine the best care path for his patients.
As an assistant professor at UC San Diego School of Medicine, he instructs medical students, residents, and fellows in the Department of Radiology. Dr. Berman finds mentoring future clinicians and leaders in interventional radiologists extremely rewarding.
He is energized by the ability to conduct cutting-edge research to expand and improve the delivery of minimally invasive procedures. Dr. Berman is actively engaged in clinical trials directed toward primary and metastatic liver disease treatments, specifically the improved use of Yttrium 90 Radioembolization.
He completed an internship and interventional radiology residency at UC San Diego School of Medicine, where he was the first integrated interventional radiology resident graduate. Dr. Berman was chief diagnostic radiology resident in 2018-2019 and chief interventional radiology resident in 2019-2020. He earned his medical degree from Case Western Reserve University School of Medicine in Cleveland, Ohio.
Dr. Berman is a member of the Society of Interventional Radiology, the Society of Interventional Oncology and the Radiologic Society of North America.
In his free time, he enjoys running, hiking and astrophotography.

Visit UCSD Health to learn more about Dr. Zach Berman.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page